The Effects of Blood Flow Restriction Aerobic Exercise on Body Composition, Muscle Strength, Blood Biomarkers, and Cardiovascular Function: A Narrative Review.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI, [2000-

Exercise*/physiology ; Biomarkers*/blood ; Muscle Strength*/physiology ; Body Composition*; Resistance Training/methods ; Humans ; Regional Blood Flow

Blood flow restriction exercise has emerged as a promising alternative, particularly for elderly individuals and those unable to participate in high-intensity exercise. However, existing research has predominantly focused on blood flow restriction resistance exercise. There remains a notable gap in understanding the comprehensive effects of blood flow restriction aerobic exercise (BFRAE) on body composition, lipid profiles, glycemic metabolism, and cardiovascular function. This review aims to explore the physiological effects induced by chronic BFRAE. Chronic BFRAE has been shown to decrease fat mass, increase muscle mass, and enhance muscular strength, potentially benefiting lipid profiles, glycemic metabolism, and overall function. Thus, the BFRAE offers additional benefits beyond traditional aerobic exercise effects. Notably, the BFRAE approach may be particularly suitable for individuals with low fitness levels, those prone to injury, the elderly, obese individuals, and those with metabolic disorders.

J Appl Physiol (1985). 2015 Apr 15;118(8):1075-83. (PMID: 25749442)
Endocrinol Metab (Seoul). 2020 Mar;35(1):1-6. (PMID: 32207258)
Clin Physiol Funct Imaging. 2011 Sep;31(5):411-3. (PMID: 21771263)
Res Integr Peer Rev. 2019 Mar 26;4:5. (PMID: 30962953)
Clin Physiol Funct Imaging. 2022 Jul;42(4):241-249. (PMID: 35357762)
Acta Physiol Hung. 2012 Dec;99(4):392-9. (PMID: 23238541)
World J Methodol. 2017 Jun 26;7(2):46-54. (PMID: 28706859)
Res Sports Med. 2022 Jan-Feb;30(1):41-49. (PMID: 33593160)
J Strength Cond Res. 2012 Mar;26(3):611-7. (PMID: 22310510)
J Exerc Sci Fit. 2022 Jan;20(1):62-69. (PMID: 35024049)
Metabolism. 2019 Sep;98:1-15. (PMID: 31199953)
Eur J Sport Sci. 2018 Apr;18(3):397-406. (PMID: 29343183)
Physiol Behav. 2021 Oct 1;239:113500. (PMID: 34174326)
Sports Med. 2018 Feb;48(2):361-378. (PMID: 29043659)
Eur J Appl Physiol. 2018 Sep;118(9):1903-1909. (PMID: 29951915)
J Appl Physiol (1985). 2000 Jan;88(1):61-5. (PMID: 10642363)
Curr Opin Clin Nutr Metab Care. 2001 Nov;4(6):521-6. (PMID: 11706287)
Int J Environ Res Public Health. 2021 Dec 24;19(1):. (PMID: 35010428)
Gene. 2016 Dec 15;594(2):229-237. (PMID: 27613141)
Anatol J Cardiol. 2022 Aug;26(8):598-607. (PMID: 35924286)
J Geriatr Phys Ther. 2010 Jan-Mar;33(1):34-40. (PMID: 20503732)
J Strength Cond Res. 2016 May;30(5):1453-61. (PMID: 26439780)
Clin Physiol Funct Imaging. 2011 Nov;31(6):472-6. (PMID: 21981459)
Int J Environ Res Public Health. 2022 Sep 21;19(19):. (PMID: 36231251)
Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1440-52. (PMID: 26342064)
J Sports Sci Med. 2011 Jun 01;10(2):338-40. (PMID: 24149880)
J Appl Physiol (1985). 2000 Jun;88(6):2097-106. (PMID: 10846023)
Metabolism. 2010 Oct;59(10):1510-9. (PMID: 20199783)
PLoS One. 2018 Mar 29;13(3):e0194776. (PMID: 29596452)
Front Physiol. 2021 Sep 01;12:722848. (PMID: 34539445)
Int J Cardiol. 2010 May 28;141(2):122-31. (PMID: 19910061)
Clin J Sport Med. 2010 May;20(3):218-9. (PMID: 20445366)
Diabetes Metab Syndr. 2019 Mar - Apr;13(2):1449-1455. (PMID: 31336505)
Acta Physiol (Oxf). 2018 Jun;223(2):e13045. (PMID: 29383885)
Cold Spring Harb Perspect Med. 2018 Apr 2;8(4):. (PMID: 28432115)
J Appl Physiol (1985). 2007 Sep;103(3):903-10. (PMID: 17569770)
J Sports Sci Med. 2010 Jun 01;9(2):224-30. (PMID: 24149689)
Physiol Meas. 2019 Jun 04;40(5):055001. (PMID: 30965312)
Acta Physiol Scand. 1979 Feb;105(2):222-7. (PMID: 420021)
J Hum Kinet. 2014 Nov 12;43:79-85. (PMID: 25713647)
Sports Med. 2003;33(8):599-613. (PMID: 12797841)
J Appl Physiol (1985). 2010 May;108(5):1199-209. (PMID: 20150565)
Int J Environ Res Public Health. 2021 Oct 30;18(21):. (PMID: 34769957)
Eur J Appl Physiol. 2010 Jan;108(1):147-55. (PMID: 19760431)
Lancet. 1993 May 22;341(8856):1330-2. (PMID: 8098459)
Cardiovasc Res. 2023 Mar 17;119(1):283-293. (PMID: 35709326)
Biomolecules. 2021 May 01;11(5):. (PMID: 34062764)
Am J Physiol Cell Physiol. 2019 Dec 1;317(6):C1061-C1078. (PMID: 31461340)
Front Cardiovasc Med. 2020 Jun 09;7:100. (PMID: 32582769)
Biomed Pharmacother. 2019 Sep;117:109106. (PMID: 31200253)
Am J Physiol. 1983 Sep;245(3):H481-6. (PMID: 6614196)
Muscle Nerve. 2016 Mar;53(3):438-45. (PMID: 26137897)
Eur J Appl Physiol. 2002 Feb;86(4):308-14. (PMID: 11990743)
Med Sci Sports Exerc. 2011 Jul;43(7):1334-59. (PMID: 21694556)
Physiol Behav. 2018 Apr 1;187:20-23. (PMID: 28843891)
Nitric Oxide. 2010 May 15;22(4):304-15. (PMID: 20188204)
Front Physiol. 2022 Jul 06;13:924557. (PMID: 35874535)
Eur J Appl Physiol. 2015 Nov;115(11):2293-302. (PMID: 26142277)
Healthcare (Basel). 2022 Sep 16;10(9):. (PMID: 36141401)
Acta Physiol Scand Suppl. 1994;615:1-50. (PMID: 8140900)
Medicine (Baltimore). 2021 May 7;100(18):e25794. (PMID: 33950976)
Eur J Appl Physiol Occup Physiol. 1992;64(6):552-6. (PMID: 1618195)
J Cardiovasc Risk. 1996 Apr;3(2):213-9. (PMID: 8836866)
PLoS One. 2013 Jul 30;8(7):e65174. (PMID: 23935815)
Cell Mol Life Sci. 2008 Nov;65(23):3737-55. (PMID: 18810325)
Diabetes Metab Syndr Obes. 2014 Jun 24;7:241-53. (PMID: 25018645)
J Appl Physiol (1985). 1995 Mar;78(3):976-89. (PMID: 7775344)
Nat Cell Biol. 2001 Nov;3(11):1014-9. (PMID: 11715023)
Clin J Sport Med. 2022 Sep 1;32(5):531-545. (PMID: 36083329)
J Physiol. 2009 Jul 15;587(Pt 14):3691-701. (PMID: 19470781)
Scand J Med Sci Sports. 2016 Sep;26(9):1017-25. (PMID: 26369387)
Sports Med. 2015 Mar;45(3):313-25. (PMID: 25430600)
Am J Physiol. 1987 Nov;253(5 Pt 2):H1199-207. (PMID: 3688260)
Am J Physiol Endocrinol Metab. 2000 Apr;278(4):E669-76. (PMID: 10751201)
Front Physiol. 2016 Dec 27;7:637. (PMID: 28082907)
J Appl Physiol (1985). 2021 Dec 1;131(6):1731-1749. (PMID: 34554017)
Eur J Appl Physiol. 2017 Jul;117(7):1493-1499. (PMID: 28501908)
J Physiol. 2000 Oct 1;528 Pt 1:221-6. (PMID: 11018120)
Sports Med. 2005;35(4):339-61. (PMID: 15831061)
Lancet Diabetes Endocrinol. 2014 Oct;2(10):819-29. (PMID: 24731660)
Biochem Soc Trans. 2002 Nov;30(Pt 6):1064-70. (PMID: 12440973)
Eur J Appl Physiol. 2016 Apr;116(4):749-57. (PMID: 26822582)
J Strength Cond Res. 2016 Jul;30(7):2064-8. (PMID: 26677831)
Clin Physiol Funct Imaging. 2017 Jul;37(4):379-383. (PMID: 26517965)
Arthrosc Sports Med Rehabil. 2022 Jan 28;4(1):e71-e76. (PMID: 35141538)
N Engl J Med. 1990 Mar 29;322(13):882-9. (PMID: 2314422)
Endocrinol Metab Clin North Am. 2012 Jun;41(2):297-322, vi. (PMID: 22682632)
J Appl Physiol (1985). 2020 May 1;128(5):1423-1431. (PMID: 32324479)
Phys Sportsmed. 2018 Feb;46(1):129-134. (PMID: 29172848)
J Int Med Res. 2021 Sep;49(9):3000605211039564. (PMID: 34486432)
Healthcare (Basel). 2020 Dec 17;8(4):. (PMID: 33348642)
J Appl Physiol (1985). 1998 Nov;85(5):1629-34. (PMID: 9804562)
Atherosclerosis. 2016 May;248:123-31. (PMID: 27016614)
J Appl Physiol (1985). 2006 May;100(5):1460-6. (PMID: 16339340)
Angiology. 2011 Jan;62(1):81-6. (PMID: 20682613)
Nat Med. 2013 Jan;19(1):101-6. (PMID: 23202294)
BMC Sports Sci Med Rehabil. 2021 Feb 12;13(1):12. (PMID: 33579336)
J Sports Sci Med. 2010 Sep 01;9(3):452-8. (PMID: 24149640)
J Clin Invest. 2004 Aug;114(4):495-503. (PMID: 15314686)
N Engl J Med. 2003 Apr 24;348(17):1625-38. (PMID: 12711737)
Am J Physiol. 1999 Jan;276(1):E188-95. (PMID: 9886966)
Hypertension. 2017 Jun;69(6):1045-1052. (PMID: 28438905)
Front Physiol. 2018 Oct 09;9:1376. (PMID: 30356748)
Biomed Pharmacother. 2022 Feb;146:112563. (PMID: 35062059)
Auton Neurosci. 2020 Nov;228:102698. (PMID: 32861944)
J Appl Physiol (1985). 2006 May;100(5):1443-4. (PMID: 16614363)
J Am Coll Cardiol. 2022 Dec 20;80(25):2361-2371. (PMID: 36368511)
J Proteome Res. 2020 Apr 3;19(4):1383-1391. (PMID: 32096398)
Sports Med. 2019 Jan;49(1):95-108. (PMID: 30306467)
J Appl Physiol (1985). 2006 Dec;101(6):1616-22. (PMID: 16902061)
Eur J Appl Physiol. 2000 Mar;81(5):418-27. (PMID: 10751104)
J Sports Sci. 2009 Mar;27(5):479-89. (PMID: 19253083)
Med Hypotheses. 2011 Nov;77(5):748-52. (PMID: 21840132)
Eur J Clin Nutr. 2003 Dec;57 Suppl 2:S69-74. (PMID: 14681716)
Sports Med. 2015 Feb;45(2):187-200. (PMID: 25249278)
J Sports Med Phys Fitness. 2021 Jul;61(7):877-884. (PMID: 33314880)
Int J Sports Med. 2017 Nov;38(13):1009-1016. (PMID: 28965344)

NRF-2022R1A2C1003657 National Research Foundation of Korea (NRF); Research Grant in 2021 Incheon National University

Keywords: cardiovascular function; elderly; fat mass; glycemic metabolism; lipid profile; muscle mass; obesity; sarcopenia

0 (Biomarkers)

Date Created: 20240914 Date Completed: 20240914 Latest Revision: 20240916

20260130

PMC11394695

10.3390/ijms25179274

39273223